Evaluation of prognostic nutritional index in chemotherapy of lung cancer
Nakai, Y.; Saito, J.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(3): 493-496
1991
ISSN/ISBN: 0385-0684 PMID: 1706172 Document Number: 377573
Document emailed within 1 workday
Related Documents
Yoshimatsu, K.; Yokomizo, H.; Yano, Y.; Okayama, S.; Sakuma, A.; Satake, M.; Sagawa, M.; Matsumoto, A.; Fjimoto, T.; Asaka, S.; Usui, T.; Yamaguchi, K.; Shiozawa, S.; Shimakawa, T.; Katsube, T.; Kato, H.; Naritaka, Y. 2016: Preoperative Prognostic Nutritional Index in Elderly Patients Over 80 Years Old Who Underwent Curative Resection for Colorectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1529-1531Thongprasert, S.; Intarapak, S.; Saengsawang, P.; Thaikla, K. 2005: Reliability of the Thai-modified Function Living Index Cancer questionnaire version 2 (T-FLIC 2) for the evaluation of quality of life in non-small cell lung cancer patients Journal of the Medical Association of Thailand 88(12): 1809-1815
Crvenkova, S.; Pesevska, M. 2015: Important prognostic factors for the long-term survival in non-small cell lung cancer patients treated with combination of chemotherapy and conformal radiotherapy Journal of Buon: Official Journal of the Balkan Union of Oncology 20(3): 775-781
Sakuma, F.; Kuroda, M.; Takagi, T.; Terashima, K.; Ohishi, A.; Noguchi, S.; Mizuno, A. 1999: Evaluation of chemotherapy with docetaxel and cisplatin in advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 927-932
Poddubnyĭ, B.K. 1985: Endoscopic diagnosis and evaluation of the effectiveness of combination chemotherapy of small cell lung cancer Voprosy Onkologii 31(10): 18-21
Xu, Y.-H.; Chen, Z.-W.; Ye, X.-Y.; Lu, S. 2008: Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients Zhonghua Zhong Liu Za Zhi 30(9): 716-719
Pasqualetti, P.; Colantonio, D.; Collacciani, A.; Casale, R.; Natali, G. 1991: Classification and prognostic evaluation in multiple myeloma. A retrospective study of relationship of survivals and responses to chemotherapy to immunological types, 20 single prognostic factors, 15 clinical staging systems, and 6 morphological classifications Panminerva Medica 33(2): 93-110
Hotta, T.; Takifuji, K.; Arii, K.; Yokoyama, S.; Matsuda, K.; Higashiguchi, T.; Tominaga, T.; Oku, Y.; Yamaue, H. 2006: Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival Anticancer Research 26(2b): 1425-1432
Mori, A.; Hirose, T.; Tamura, A.; Kusaka, K.; Matsui, H.; Ohta, K. 2016: Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(6): 723-726
Bahl, A.; Chander, S.; Julka, P.K.; Rath, G.K.; Sharma, D.N.; Kumar, A.; Nair, O. 2006: Micronuclei evaluation of reduction in neoadjuvant chemotherapy related acute toxicity in locally advanced lung cancer: an indian experience Journal of the Association of Physicians of India 54: 191-195
Kimura, O.; Sugamura, K.; Kijima, T.; Kurayoshi, K.; Makino, M.; Kaibara, N. 1996: DNA index as a significant prognostic indicator of colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(Suppl 2): 118-124
Bagattini Mari, J.C.; Nin Alvarez, L.A.; Larre Borges, U.; Mancuso, G.; López, A.M.; Larre Borges, P. 1984: Nutritional and prognostic factors in cancer patients Revista de Gastroenterologia de Mexico 49(4): 227-234
Williams, C.J.; Woods, R.; Levi, J.; Page, J. 1988: Chemotherapy for non-small cell lung cancer: a randomized trial of cisplatin/vindesine v no chemotherapy Seminars in Oncology 15(6 Suppl 7: 58-61
Takatsuki, K.; Kado, T.; Satouchi, M.; Nakajima, T.; Nagai, K.; Ohsugi, F.; Yanagida, E.; Minegaki, A. 1998: Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 403-408
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Momozane, T.; Higashiyama, M.; Maeda, J.; Okami, J.; Oda, K.; Imamura, F.; Yoneda, K.; Takenaka, A.; Kodama, K. 2009: Surgical treatment for the second double lung cancers following chemotherapy for small cell lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 62(2): 117-121
Miyamoto, T.; Morita, S.; Tsunemoto, H.; Oka, K.; Otsu, H. 1987: Acute squamous metaplasia of the whole lung after combined radiation and chemotherapy in advanced lung cancer Gan no Rinsho. Japan Journal of Cancer Clinics 33(1): 89-96
Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75
Høgdall, C.K.; Nørgaard-Pedersen, B.; Mogensen, O. 2002: The prognostic value of pre-operative serum tetranectin, CA-125 and a combined index in women with primary ovarian cancer Anticancer Research 22(3): 1765-1768